Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature

[1]  F. Roviello,et al.  E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. , 2011, European journal of cancer.

[2]  R. Wilcox,et al.  Hereditary Diffuse Gastric Cancer: Multidisciplinary Case Report with Review of the Literature , 2011, Pathology research international.

[3]  A. Jakubowska,et al.  CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland , 2010, Familial Cancer.

[4]  C. Caldas,et al.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research , 2010, Journal of Medical Genetics.

[5]  F. Roviello,et al.  Familial gastric cancer and Li-Fraumeni syndrome. , 2010, European journal of cancer care.

[6]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[7]  H. Hoefler,et al.  Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members , 2010, European journal of gastroenterology & hepatology.

[8]  P. Guilford,et al.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice , 2010, Gastric Cancer.

[9]  S. Cai,et al.  [Associations of E-cadherin gene (CDH1) and hereditary gastric cancer in China]. , 2009, Zhonghua wai ke za zhi [Chinese journal of surgery].

[10]  F. Roviello,et al.  Different Pathological Features and Prognosis in Gastric Cancer Patients Coming From High-Risk and Low-Risk Areas of Italy , 2009, Annals of surgery.

[11]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[12]  R. Seruca,et al.  E-cadherin mutations and cell motility: a genotype-phenotype correlation. , 2009, Experimental cell research.

[13]  S. Ghaffari,et al.  Novel human pathological mutations. Gene symbol: CDH1. Disease: gastric cancer. , 2009, Human genetics.

[14]  S. Chin,et al.  Germline CDH1 deletions in hereditary diffuse gastric cancer families , 2009, Human molecular genetics.

[15]  F. van Roy,et al.  Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. , 2008, Human molecular genetics.

[16]  Yoko Ito,et al.  Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer , 2008, The Journal of pathology.

[17]  A. Sézeur,et al.  Usefulness of Prophylactic Gastrectomy in a Novel Large Hereditary Diffuse Gastric Cancer (HDGC) Family , 2008, The American Journal of Gastroenterology.

[18]  R. Jeffrey,et al.  Risk-reducing Total Gastrectomy for Germline Mutations in E-cadherin (CDH1): Pathologic Findings With Clinical Implications , 2008, The American journal of surgical pathology.

[19]  F. Roviello,et al.  E-cadherin and hereditary diffuse gastric cancer. , 2007, Surgery.

[20]  F. Roviello,et al.  Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  B. Fernandez,et al.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.

[22]  F. Roviello,et al.  Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  B. Boman,et al.  Identification of seven novel germline mutations in the human E‐cadherin (CDH1) Gene , 2007, Human mutation.

[24]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Xiao-mei Zhang,et al.  Germline mutations and polymorphic variants in MMR, E‐cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China , 2006, International journal of cancer.

[26]  C. Caldas,et al.  A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  D. Huntsman,et al.  CDH1/E-cadherin germline mutations in early-onset gastric cancer , 2006, Journal of Medical Genetics.

[28]  R. Seruca,et al.  Genetics of hereditary diffuse gastric cancer: progress and future challenges. , 2006, Future oncology.

[29]  Mario Plebani,et al.  Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[30]  P. Lewis.  Novel human pathological mutations  , 2006, Human Genetics.

[31]  D. Huntsman,et al.  Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management , 2005, Clinical Cancer Research.

[32]  M Vekemans,et al.  Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer , 2005, Journal of Medical Genetics.

[33]  M. Joyce,et al.  CDH1 associated gastric cancer: a report of a family and review of the literature. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[34]  Y. Wan,et al.  [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds]. , 2004, Zhonghua wai ke za zhi [Chinese journal of surgery].

[35]  R. Seruca,et al.  E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. , 2004, European journal of cancer.

[36]  W. Foulkes,et al.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.

[37]  X. H. Chen,et al.  Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[38]  H. Höfler,et al.  Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients , 2004, Journal of Medical Genetics.

[39]  D. Palli,et al.  Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy , 2001, Cancer Causes & Control.

[40]  D. Huntsman,et al.  E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. , 2003, Human molecular genetics.

[41]  M. Magnani,et al.  Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy , 2003, Tumori.

[42]  J. Yokota,et al.  Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer. , 2003, Japanese journal of clinical oncology.

[43]  J. Yokota,et al.  E‐cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer , 2002, International journal of cancer.

[44]  T. Merriman,et al.  Novel germline CDH1 mutations in hereditary diffuse gastric cancer families , 2002, Human mutation.

[45]  L. Aaltonen,et al.  Screening E‐cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred , 2002, Human mutation.

[46]  H. Grönberg,et al.  Germline mutations in E‐cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer , 2002, International journal of cancer.

[47]  L. Aaltonen,et al.  A germline E-cadherin mutation in a family with gastric and colon cancer. , 2001, International journal of molecular medicine.

[48]  J. Raoul,et al.  A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. , 2001, European journal of gastroenterology & hepatology.

[49]  L. Aaltonen,et al.  E-cadherinis not frequently mutated in hereditary gastric cancer , 2001, Journal of medical genetics.

[50]  J. Yokota,et al.  Familial gastric cancer: overview and guidelines for management* , 1999, Journal of medical genetics.

[51]  H. Höfler,et al.  Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. , 1999, The American journal of pathology.

[52]  J. Yokota,et al.  Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. , 1999, Carcinogenesis.

[53]  J. Ku,et al.  Germline mutations of E-cadherin gene in Korean familial gastric cancer patients , 1999, Journal of Human Genetics.

[54]  D. Evans,et al.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. , 1999, Human molecular genetics.

[55]  S. Markowitz,et al.  E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer , 1999, Human mutation.

[56]  Kylie L. Gorringe,et al.  Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. , 1998, Cancer research.

[57]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[58]  C. Holcombe.  Helicobacter pylori: the African enigma. , 1992, Gut.